## Investigation of Choice for Beta-Blocker–Induced Conduction Abnormality ### Rationale for 12-Lead ECG **Key Point:** A 12-lead ECG is the gold standard and first-line investigation to detect beta-blocker–induced bradycardia and conduction delays (PR prolongation, AV block, bundle branch block). **High-Yield:** Beta-blockers slow AV nodal conduction by reducing automaticity and increasing the refractory period. The ECG will directly visualize: - PR interval prolongation (first-degree AV block) - Second- or third-degree AV block (if severe) - Bradycardia with normal QRS (sinus bradycardia) - Bundle branch block patterns (rare but possible) ### Why 12-Lead ECG Is Superior | Investigation | Utility | Limitation | |---|---|---| | **12-lead ECG** | Immediate, specific detection of conduction abnormalities and rhythm | Single snapshot; does not capture paroxysmal events | | **24-hour Holter** | Detects paroxysmal arrhythmias and symptomatic bradycardia episodes | Time-consuming; not needed for diagnosis of baseline conduction delay | | **Echocardiography** | Assesses cardiac structure and function | Does not directly assess electrical conduction; not indicated for conduction abnormality | | **Cardiac biomarkers** | Detect myocardial injury | Irrelevant for conduction assessment; would be normal in beta-blocker bradycardia | **Clinical Pearl:** In a symptomatic patient with suspected beta-blocker–induced bradycardia or conduction block, the ECG provides immediate diagnostic clarity and guides the decision to reduce the dose or discontinue the drug. ### Management Implication If the ECG shows significant PR prolongation or AV block, the beta-blocker should be reduced or switched to a more selective agent (e.g., atenolol) or a different drug class (e.g., ACE inhibitor or calcium channel blocker). [cite:KD Tripathi 8e Ch 12]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.